| P50 | author | Isabella Guzzo | Q86690478 |
| | Federica Zotta | Q89450521 |
| P2093 | author name string | Francesca Diomedi-Camassei | |
| | Federica Morolli | |
| | Luca Dello Strologo | |
| P2860 | cites work | Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients | Q80611071 |
| | Repeat true surveillance biopsies in kidney transplantation | Q84005648 |
| | What do we need to do to make protocol biopsies standard of care or should we discontinue doing? | Q84417644 |
| | Changing Kidney Allograft Histology Early Posttransplant: Prognostic Implications of 1-Year Protocol Biopsies | Q85903520 |
| | Safety of kidney biopsy in pediatric transplantation: a report of the Controlled Clinical Trials in Pediatric Transplantation Trial of Induction Therapy Study Group | Q33539816 |
| | The significance of subclinical rejection and the value of protocol biopsies | Q36517003 |
| | Protocol transplant biopsies: are they really needed? | Q36910297 |
| | Protocol transplant biopsies: an underutilized tool in kidney transplantation | Q36910301 |
| | Banff 2011 Meeting report: new concepts in antibody-mediated rejection | Q37058043 |
| | Surveillance biopsies in children post-kidney transplant | Q37906368 |
| | Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice | Q37907391 |
| | The Banff classification revisited | Q38067050 |
| | Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies | Q38130585 |
| | The value of long-term protocol biopsies after kidney transplantation | Q38212981 |
| | Kidney transplantation in children | Q38237543 |
| | Pediatric kidney transplantation: a historical review | Q38812385 |
| | Surveillance biopsies after paediatric kidney transplantation: A review | Q38866277 |
| | Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Protocol biopsy-driven interventions after pediatric renal transplantation | Q42905749 |
| | Patterns of chronic injury in pediatric renal allografts. | Q43166683 |
| | Effect of histological damage on long-term kidney transplant outcome | Q43547328 |
| | Early treatment of acute rejections gives favorable long-term function after renal transplantation in small children | Q43860447 |
| | The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy | Q44378940 |
| | Comparison of the glomerular filtration rate in children by the new revised Schwartz formula and a new generalized formula. | Q44403278 |
| | Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy | Q44503856 |
| | Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. | Q44792449 |
| | Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 |
| | Safety and risk stratification of percutaneous biopsies of adult-sized renal allografts in infant and older pediatric recipients | Q46503948 |
| | Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children | Q46790074 |
| | The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. | Q48112113 |
| | Low incidence of adverse events in outpatient pediatric renal allograft biopsies | Q50176492 |
| | The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. | Q51740341 |
| | Early protocol biopsies in pediatric renal transplantation: interest for the adaptation of immunosuppression. | Q54434558 |
| | The Banff 97 working classification of renal allograft pathology | Q59314413 |
| | Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft Loss | Q62619830 |
| | Histological findings in early routine biopsies of stable renal allograft recipients | Q72778744 |
| | Protocol biopsies should be part of the routine management of kidney transplant recipients. Pro | Q77223322 |
| | Beneficial effects of treatment of early subclinical rejection: a randomized study | Q77530459 |
| | Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation | Q77758328 |
| | Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') | Q79921621 |
| | Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants | Q79967854 |
| P433 | issue | 11 | |
| P304 | page(s) | 2167-2175 | |
| P577 | publication date | 2018-07-06 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Protocol biopsies in pediatric renal transplantation: a precious tool for clinical management | |
| P478 | volume | 33 | |